Vicar & Lay partners with VC and PE firms to build brands across their life sciences portfolios, without adding headcount or overhead.
Schedule a Conversation
Get in Touch
Your portfolio companies are developing therapies that will change medicine. But pull up their websites. Look at their pitch decks. Scan their conference materials.
Do they look like companies backed by your firm?
In most cases, no. The identity was built on a shoestring in the early days. The website hasn't been touched since Series A. Nobody on the team—at the company or at the firm—has the time, the expertise, or the mandate to fix it. That disconnect between what your portfolio companies are and how the world perceives them costs real value—in fundraising, in partnerships, in talent acquisition, and at exit.
That’s where we come in.
We don't work with portfolio companies who find us on Google. We work with the firms behind them—embedding directly into your value creation process at every inflection point.
Asset Branding
Identity systems for therapeutic assets and pipeline programs — built to communicate scientific credibility to investors, partners, regulators, and patients from first presentation through commercial launch.
clinical trial Branding
Branding clinical trials can help drive recruitment and establish market-ready equity for your future product, especially in a crowded space. Moving beyond generic code names and trial designations, we create compelling identities that build trust with the professional audience and help patients navigate their options. We start by building a brand strategy and name, then dive into visual development, including logo and identity guidelines to ensure consistency across print and digital assets for you and your recruitment team.
corporate Branding
Full brand architecture for portfolio companies — from naming and positioning through visual identity, verbal identity, and every application that touches the market. Specializing in post-acquisition rebrands and PE platform roll-ups.
Your portfolio companies’ science is world-class.
Their brands should be too.
Schedule a Portfolio Brand Assessment
Vicar & Lay partners with VC and PE firms to build brands across their life sciences portfolios, without adding headcount or overhead.
Schedule a Conversation
Get in Touch
Team
Your portfolio companies are developing therapies that will change medicine. But pull up their websites. Look at their pitch decks. Scan their conference materials.
Do they look like companies backed by your firm?
In most cases, no. The identity was built on a shoestring in the early days. The website hasn't been touched since Series A. Nobody on the team—at the company or at the firm—has the time, the expertise, or the mandate to fix it. That disconnect between what your portfolio companies are and how the world perceives them costs real value—in fundraising, in partnerships, in talent acquisition, and at exit.
That’s where we come in.
We don't work with portfolio companies who find us on Google. We work with the firms behind them—embedding directly into your value creation process at every inflection point.
Asset Branding
Identity systems for therapeutic assets and pipeline programs — built to communicate scientific credibility to investors, partners, regulators, and patients from first presentation through commercial launch.
clinical trial Branding
Branding clinical trials can help drive recruitment and establish market-ready equity for your future product, especially in a crowded space. Moving beyond generic code names and trial designations, we create compelling identities that build trust with the professional audience and help patients navigate their options. We start by building a brand strategy and name, then dive into visual development, including logo and identity guidelines to ensure consistency across print and digital assets for you and your recruitment team.
corporate Branding
Full brand architecture for portfolio companies — from naming and positioning through visual identity, verbal identity, and every application that touches the market. Specializing in post-acquisition rebrands and PE platform roll-ups.
Your portfolio companies’ science is world-class.
Their brands should be too.
Schedule a Portfolio Brand Assessment
Learn More
Vicar & Lay partners with VC and PE firms to build brands across their life sciences portfolios, without adding headcount or overhead.
Schedule a Conversation
Get in Touch
Your portfolio companies are developing therapies that will change medicine. But pull up their websites. Look at their pitch decks. Scan their conference materials.
Do they look like companies backed by your firm?
In most cases, no. The identity was built on a shoestring in the early days. The website hasn't been touched since Series A. Nobody on the team—at the company or at the firm—has the time, the expertise, or the mandate to fix it. That disconnect between what your portfolio companies are and how the world perceives them costs real value—in fundraising, in partnerships, in talent acquisition, and at exit.
That’s where we come in.
We don't work with portfolio companies who find us on Google. We work with the firms behind them—embedding directly into your value creation process at every inflection point.
Asset Branding
Identity systems for therapeutic assets and pipeline programs — built to communicate scientific credibility to investors, partners, regulators, and patients from first presentation through commercial launch.
clinical trial Branding
Branding clinical trials can help drive recruitment and establish market-ready equity for your future product, especially in a crowded space. Moving beyond generic code names and trial designations, we create compelling identities that build trust with the professional audience and help patients navigate their options. We start by building a brand strategy and name, then dive into visual development, including logo and identity guidelines to ensure consistency across print and digital assets for you and your recruitment team.
corporate Branding
Full brand architecture for portfolio companies — from naming and positioning through visual identity, verbal identity, and every application that touches the market. Specializing in post-acquisition rebrands and PE platform roll-ups.
Your portfolio companies’ science is world-class.
Their brands should be too.
Schedule a Portfolio Brand Assessment
Team